Another member of the family, expressed mainly in the brain, neuronal PAS domain-containing protein 4 (NPAS4) has been proposed as a novel therapeutic target for depression and neurodegenerative diseases [15] and as a component of new stroke therapies [16]. Here, NPAS4 is linked to depressive symptom measurement.